Santander UK (SNTUF) profit hit by motor finance charge after TSB deal
Santander UK plc reported half-year 2026 results shaped by the completed acquisition of TSB on 30 April, which added 4 million customers and 4,500 colleagues, making it a leading UK retail bank. Profit before tax was £517m, down 31% from £746m in H1-25, mainly due to a £179m provision charge in Q1-26 relating to historical motor finance commission payments and higher restructuring costs. Net interest income rose 8% to £2,369m, and non-interest income more than doubled to £130m, largely from TSB and stronger fee income, while operating expenses stayed broadly flat through simplification and automation. Credit impairment charges increased to £277m from £105m, including a day 1 £62m charge on acquired TSB balances, and TSB recorded a £25m pre-tax loss for May–June.
Customer loans grew to £235.3bn (from £197.4bn), with mortgages at £202.6bn, and customer deposits rose to £220.7bn (from £183.6bn), largely reflecting TSB plus broad-based growth. Asset quality remained strong, with a Stage 3 ratio of 0.86%, down 32bps since December 2025; arrears over 90 days were low across products. The total ECL allowance increased to £889m from £812m, driven by TSB and a weaker macroeconomic outlook. Capital and liquidity stayed robust, with a CET1 ratio of 14.2% (15.8% at December 2025), an LCR of 163%, and £6.8bn equivalent of term issuance. Management expects continued net lending growth, a stable net interest margin, and further cost efficiencies in 2026 while closely monitoring geopolitical and macroeconomic risks.
Positive
- TSB acquisition materially expanded scale, lifting customer loans to £235.3bn and deposits to £220.7bn while maintaining a low Stage 3 ratio of 0.86% and a strong CET1 capital ratio of 14.2%.
Negative
- Profit before tax fell 31% to £517m, driven by a £179m provision related to historical motor finance commission payments, higher restructuring costs, and increased credit impairment charges of £277m with total ECL rising to £889m.
Filing Explained
TSB is acquired, but its legal transfer and full risk-framework integration remain pending through the first half of 2027.
As a Form 6-K, this interim report furnishes material information from Santander UK’s home market. The TSB acquisition completed on
Until the planned transfer in the first half of
The next disclosed milestones are work to align TSB’s significant-increase-in-credit-risk criteria in the second half of
Key Figures
Key Terms
Stage 3 ratio financial
Common Equity Tier 1 (CET1) capital ratio financial
Liquidity Coverage Ratio (LCR) financial
Expected Credit Loss (ECL) financial
Purchased or Originated Credit-Impaired (POCI) financial
Significant Increase in Credit Risk (SICR) financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did Santander UK plc (SNTUF) perform financially in H1 2026?
What impact did the TSB acquisition have on Santander UK (SNTUF)?
Why did credit impairment charges increase at Santander UK (SNTUF)?
How strong is Santander UK’s (SNTUF) capital and liquidity position as of 30 June 2026?
What is the asset quality picture for Santander UK (SNTUF) in H1 2026?
What outlook does Santander UK (SNTUF) provide for 2026?
Santander UK plc | ||||
Half Yearly Financial Report 2026 | ||||
Contents | ||||
CEO review | 2 | |||
Financial overview | 3 | |||
Risk review | 7 | |||
Financial statements | 44 | |||
Shareholder information | 70 | |||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 30 June 2025 | |
£m | £m | |
Net interest income | 2,369 | 2,194 |
Non-interest income1, 2 | 130 | 64 |
Net operating income1 | 2,499 | 2,258 |
Operating expenses before credit impairment charges, restructuring and specific provisions2 | (1,339) | (1,315) |
Credit impairment charges | (277) | (105) |
Restructuring and specific provisions2 | (366) | (92) |
Total credit impairment charges, restructuring and specific provisions | (643) | (197) |
Profit before tax | 517 | 746 |
Tax on profit | (143) | (195) |
Profit after tax | 374 | 551 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Assets | 30 June 2026 | 31 December 2025 |
£bn | £bn | |
Customer loans | 235.3 | 197.4 |
Loans to JVs, accrued interest, ECL and other | 5.1 | 5.2 |
Loans and advances to customers | 240.4 | 202.6 |
Cash at central banks | 38.3 | 29.4 |
Reverse repurchase agreements | 10.7 | 17.7 |
Other financial assets | 14.7 | 11.1 |
Other assets - non-interest earning | 8.2 | 6.0 |
Total assets | 312.3 | 266.8 |
Liabilities and Equity | 30 June 2026 | 31 December 2025 |
£bn | £bn | |
Customer deposits | 220.7 | 183.6 |
Deposits from JVs, accrued interest and other | 3.9 | 3.7 |
Deposits by customers | 224.6 | 187.3 |
Financial liabilities at amortised cost | 57.7 | 50.0 |
Repurchase agreements | 6.4 | 9.0 |
Other liabilities - non-interest bearing | 6.6 | 5.4 |
Total liabilities | 295.3 | 251.7 |
Shareholders' equity | 17.0 | 15.1 |
Total liabilities and equity | 312.3 | 266.8 |
30 June 2026 | 31 December 2025 | |
£bn | £bn | |
Retail & Business Banking | 192.6 | 155.7 |
–Current accounts | 69.1 | 59.4 |
–Savings | 108.4 | 82.5 |
–Business Banking | 10.1 | 8.6 |
–Other retail products | 5.0 | 5.2 |
Corporate & Commercial Banking | 24.8 | 24.4 |
Corporate Centre | 3.3 | 3.5 |
Total | 220.7 | 183.6 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Customer loans | 30 June 2026 | 31 December 2025 |
£bn | £bn | |
Retail & Business Banking | 210.8 | 173.5 |
Consumer Finance | 5.0 | 5.0 |
Corporate & Commercial Banking | 19.5 | 18.9 |
Corporate Centre | — | — |
Total | 235.3 | 197.4 |
Customer deposits | 30 June 2026 | 31 December 2025 |
£bn | £bn | |
Retail & Business Banking | 192.6 | 155.7 |
Consumer Finance | — | — |
Corporate & Commercial Banking | 24.8 | 24.4 |
Corporate Centre | 3.3 | 3.5 |
Total | 220.7 | 183.6 |
RWA | 30 June 2026 | 31 December 2025 |
£bn | £bn | |
Total | 79.8 | 67.2 |
Profit/(loss) before tax | 30 June 2026 | 30 June 2025 |
£m | £m | |
Retail & Business Banking | 562 | 567 |
Consumer Finance | (160) | 55 |
Corporate & Commercial Banking | 146 | 126 |
Corporate Centre | (31) | (2) |
Total | 517 | 746 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Risk review | |||
In this section | |||
Risk governance | 8 | ||
Credit risk | 10 | ||
Liquidity risk | 31 | ||
Capital risk | 34 | ||
Market risk | 35 | ||
Pension risk | 36 | ||
Strategic and business risk | 37 | ||
Reputational risk | 38 | ||
Non-Financial Risks: | |||
Operational risk | 39 | ||
Economic crime risk | 41 | ||
Model risk | 42 | ||
Compliance risk | 43 | ||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Credit risk is the risk of financial loss due to the default or credit quality deterioration of a customer or counterparty to which we provided credit, or for whom we assumed a financial obligation. Credit risk management In H1-26, there were no significant changes in the way we manage credit risk as described in the 2025 Annual Report, including as a result of the TSB acquisition, except as set out below for Business banking and SICR. Credit risk review In this section, we analyse our key credit risk metrics. | Key metrics Stage 3 ratio of 0.86% (2025: 1.18%). Loss allowances of £889m (2025: £812m). Balance weighted average LTV of 66% (2025: 65%) on new mortgage lending. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Base case key macroeconomic assumptions |
–House price growth: House price data presents a mixed picture but in general price growth has been modest as higher-than-expected mortgage rates have weighed on activity, evidenced by the latest decline in mortgage approvals across the market. Survey data shows buyer demand has weakened and although mortgage rates have come down, affordability constraints are set to weigh on property prices going forward. We forecast house price growth of below 1% in 2026 as demand slows. Bank Rate cuts resuming in 2027 H2 should allow a gradual improvement in property price growth to c.3%, broadly in line with average household disposable income. |
–GDP: The UK economy posted strong growth in Q1-26, expanding by 0.6% q/q. The breakdown suggests some front-loading of activity ahead of higher energy prices, particularly in the production sector, but there was a welcome rise in consumer spending and business investment. However, moving forward this strength is unlikely to continue as the economy starts to feel the full effects of higher energy prices and the spillover of this into other goods and services. Household spending is expected to remain weak as real household disposable income falls and consumer confidence remains subdued. We expect below trend growth of around 1% in 2026 and 2027, before recovering to average growth rates in 2028. |
–Unemployment rate: The labour market has gradually loosened with the unemployment rate of 4.9% in the three months to April 2026 higher than a year earlier, although it is down from 5.2% at the end of 2025. The number of payrolled employees has declined in most months since higher employment costs were announced in the October 2024 budget. With companies under pressure from rising costs, including from higher employment taxes, it is likely that some will become insolvent and although we do not envisage a large rise in unemployment, we do still expect the jobless rate to peak at 5.5% in early 2027 before falling gradually. |
–Bank Rate: The Monetary Policy Committee (MPC) maintained Bank Rate at 3.75% at the July 2026 MPC meeting as uncertainty around disruptions in energy prices and supply chains continue to keep policymakers cautious. Despite softer economic data meaning the likelihood of material second-round effects is lower, the MPC remains vigilant to inflation risks and stands ready to act. Based on the assumptions outlined above, our base case assumes the MPC raises Bank Rate to 4% in Q3-26 to help counter any second-round effects and keep financial conditions sufficiently tight. We then expect the MPC to resume interest rate cuts in the second half of 2027 until Bank Rate reaches a terminal rate of 3.25% at the start of 2028. |
–CRE price growth: Commercial property prices have been rising only modestly over the past year with annual growth averaging a little over 1% during this time. A higher interest rate profile than previously expected, which does not anticipate rate cuts until the second half of 2027, alongside lower business confidence pushes down our forecast for commercial property price growth which averages around 1.5% over the forecast period. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Economic scenarios1 | Upside | Base case | Downside 1 | Downside 2 | Weighted | |
% | % | % | % | % | ||
GDP | 2025 (actual) | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
(Calendar year annual growth rate) | 2026 | 1.2 | 0.9 | 0.4 | (1.2) | 0.6 |
2027 | 1.7 | 0.9 | (0.3) | (2.9) | 0.3 | |
2028 | 2.6 | 1.4 | 1.7 | 1.4 | 1.7 | |
2029 | 2.5 | 1.4 | 2.1 | 1.5 | 1.8 | |
2030 | 2.8 | 1.5 | 1.7 | 1.5 | 1.7 | |
2031 | 2.6 | 1.5 | 1.6 | 1.4 | 1.7 | |
Start to trough2 | n/a | n/a | (1.0) | (5.0) | (0.6) | |
5-year average increase/decrease3 | 2.2 | 1.2 | 1.1 | — | n/a | |
Bank Rate | 2025 (actual) | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 |
(at 31-Dec for each period) | 2026 | 3.50 | 4.00 | 4.50 | 3.25 | 4.00 |
2027 | 3.25 | 3.50 | 4.75 | 2.00 | 3.69 | |
2028 | 3.25 | 3.25 | 3.50 | 2.25 | 3.23 | |
2029 | 3.25 | 3.25 | 3.50 | 2.75 | 3.28 | |
2030 | 3.25 | 3.25 | 3.50 | 3.00 | 3.30 | |
2031 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | |
5-year end period | 3.25 | 3.25 | 3.50 | 3.00 | n/a | |
5-year peak | 3.75 | 4.00 | 4.75 | 3.75 | 4.00 | |
HPI | 2025 (actual) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
(Q4 annual growth rate) | 2026 | 1.3 | 0.8 | (1.1) | (11.0) | (0.9) |
2027 | 3.7 | 1.5 | (6.7) | (13.0) | (1.9) | |
2028 | 5.0 | 2.5 | (1.4) | 1.7 | 1.7 | |
2029 | 5.0 | 3.0 | 3.4 | 7.9 | 3.8 | |
2030 | 5.0 | 3.0 | 4.4 | 5.6 | 3.9 | |
2031 | 4.5 | 3.0 | 3.9 | 5.3 | 3.7 | |
Start to trough2 | n/a | n/a | (9.8) | (27.2) | (3.3) | |
5-year average increase/decrease3 | 4.2 | 2.2 | (0.3) | (2.0) | n/a | |
Unemployment | 2025 (actual) | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 |
(at 31-Dec for each period) | 2026 | 5.3 | 5.4 | 5.8 | 7.2 | 5.7 |
2027 | 4.9 | 5.4 | 6.0 | 8.3 | 5.8 | |
2028 | 4.1 | 5.2 | 5.3 | 7.5 | 5.3 | |
2029 | 4.0 | 4.9 | 4.9 | 6.7 | 4.9 | |
2030 | 4.0 | 4.6 | 4.7 | 5.2 | 4.6 | |
2031 | 4.0 | 4.4 | 4.5 | 4.7 | 4.4 | |
5-year end period | 4.0 | 4.5 | 4.6 | 4.9 | n/a | |
5-year peak | 5.3 | 5.5 | 6.1 | 8.5 | 5.9 | |
CRE price growth | 2025 (actual) | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
(Q4 annual growth rate) | 2026 | 3.6 | 0.6 | (4.3) | (13.1) | (1.8) |
2027 | 4.1 | 1.3 | (3.6) | (8.0) | (0.5) | |
2028 | 4.1 | 2.1 | (0.4) | (2.9) | 1.3 | |
2029 | 4.0 | 1.8 | 2.8 | 2.2 | 2.5 | |
2030 | 3.9 | 1.5 | 1.7 | 2.4 | 2.1 | |
2031 | 3.1 | 1.5 | 1.6 | 2.0 | 1.8 | |
Start to trough2 | n/a | n/a | (8.3) | (22.4) | (2.4) | |
5-year average increase/decrease3 | 4.1 | 1.5 | (0.7) | (4.0) | n/a |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Upside | Base case | Downside 1 | Downside 2 | Weighted | ||
% | % | % | % | % | ||
GDP | 2024 (actual) | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
(Calendar year annual growth rate) | 2025 | 1.5 | 1.4 | 1.3 | 1.3 | 1.4 |
2026 | 1.7 | 1.0 | (0.4) | (3.3) | 0.3 | |
2027 | 2.3 | 1.4 | — | (1.0) | 0.9 | |
2028 | 2.5 | 1.4 | 0.4 | 1.4 | 1.3 | |
2029 | 2.6 | 1.5 | 0.4 | 1.4 | 1.4 | |
2030 | 2.7 | 1.5 | 0.7 | 1.4 | 1.5 | |
Start to trough2 | n/a | n/a | (0.7) | (5.0) | n/a | |
5-year average increase/decrease3 | 2.3 | 1.4 | 0.2 | (0.1) | n/a | |
Bank Rate | 2024 (actual) | 4.75 | 4.75 | 4.75 | 4.75 | 4.75 |
(at 31-Dec for each period) | 2025 | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 |
2026 | 3.00 | 3.25 | 4.50 | 2.00 | 3.40 | |
2027 | 3.00 | 3.25 | 3.25 | 1.50 | 3.04 | |
2028 | 3.00 | 3.25 | 3.25 | 2.50 | 3.14 | |
2029 | 3.00 | 3.25 | 3.25 | 2.75 | 3.16 | |
2030 | 3.00 | 3.25 | 3.25 | 3.00 | 3.19 | |
5-year end period | 3.00 | 3.25 | 3.25 | 3.00 | n/a | |
5-year peak | 3.75 | 3.75 | 4.50 | 3.75 | 3.79 | |
HPI | 2024 (actual) | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
(Q4 annual growth rate) | 2025 | 2.3 | 1.5 | 0.1 | 0.3 | 1.2 |
2026 | 4.1 | 2.5 | (5.3) | (12.1) | (0.6) | |
2027 | 4.5 | 3.0 | (4.4) | (11.9) | 0.2 | |
2028 | 4.5 | 3.0 | 0.7 | (4.9) | 2.1 | |
2029 | 4.5 | 3.0 | 3.4 | 7.2 | 3.7 | |
2030 | 4.5 | 3.0 | 4.4 | 7.1 | 3.9 | |
Start to trough2 | n/a | n/a | (10.2) | (28.0) | (0.3) | |
5-year average increase/decrease3 | 4.4 | 2.9 | (0.7) | (3.7) | n/a | |
Unemployment | 2024 (actual) | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
(at 31-Dec for each period) | 2025 | 4.7 | 4.8 | 5.1 | 5.2 | 4.9 |
2026 | 4.7 | 4.9 | 5.7 | 6.8 | 5.3 | |
2027 | 4.1 | 4.7 | 5.8 | 8.5 | 5.3 | |
2028 | 4.0 | 4.4 | 5.8 | 7.9 | 5.0 | |
2029 | 4.0 | 4.3 | 5.9 | 7.1 | 4.9 | |
2030 | 4.0 | 4.3 | 6.0 | 6.4 | 4.9 | |
5-year end period | 4.0 | 4.3 | 6.0 | 6.4 | n/a | |
5-year peak | 4.7 | 4.9 | 6.0 | 8.5 | 5.3 | |
CRE price growth | 2024 (actual) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
(Q4 annual growth rate) | 2025 | 2.1 | 1.7 | (0.2) | (0.8) | 1.0 |
2026 | 6.7 | 2.2 | (3.1) | (16.8) | (0.3) | |
2027 | 5.8 | 2.5 | (1.9) | (7.2) | 1.2 | |
2028 | 3.6 | 2.2 | (0.8) | 2.5 | 1.8 | |
2029 | 4.0 | 1.9 | 0.3 | 3.0 | 2.0 | |
2030 | 2.3 | 1.5 | 2.4 | 3.9 | 2.1 | |
Start to trough2 | n/a | n/a | (6.7) | (24.1) | (0.1) | |
5-year average increase/decrease3 | 4.6 | 2.2 | (0.9) | (3.8) | n/a |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Upside | Base case | Downside 1 | Downside 2 | Weighted | |
Scenario weights | % | % | % | % | % |
30 June 2026 | 15 | 45 | 30 | 10 | 100 |
31 December 2025 | 15 | 50 | 25 | 10 | 100 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Retail & Business Banking | |||||||
Everyday Banking | |||||||
Mortgages | Credit Cards | Other | Consumer Finance | Corporate & Commercial Banking | Corporate Centre | Total | |
30 June 2026 | £m | £m | £m | £m | £m | £m | £m |
Modelled ECL | 105 | 187 | 153 | 79 | 117 | — | 641 |
Individually assessed | 7 | — | — | — | 185 | — | 192 |
ECL before Judgemental Adjustments | 112 | 187 | 153 | 79 | 302 | — | 833 |
Judgemental Adjustments | |||||||
Affordability and Cost of Living | 4 | — | 5 | — | 4 | — | 13 |
Adjustments to modelled forecast parameters | 19 | (7) | 13 | (12) | 2 | — | 15 |
Corporate single large exposure | — | — | — | — | 27 | — | 27 |
Other | 1 | — | — | — | — | — | 1 |
Total Judgemental Adjustments | 24 | (7) | 18 | (12) | 33 | — | 56 |
Total ECL | 136 | 180 | 171 | 67 | 335 | — | 889 |
Total JAs as a percentage of Total ECL (%) | 6 | ||||||
31 December 2025 | £m | £m | £m | £m | £m | £m | £m |
Modelled ECL | 104 | 160 | 115 | 74 | 110 | — | 563 |
Individually assessed | 8 | — | — | — | 180 | — | 188 |
ECL before Judgemental Adjustments | 112 | 160 | 115 | 74 | 290 | — | 751 |
Judgemental Adjustments | |||||||
Affordability and Cost of Living | 2 | — | 6 | — | 1 | — | 9 |
Adjustments to modelled forecast parameters | 23 | (5) | 13 | (11) | 5 | — | 25 |
Corporate single large exposure | — | — | — | — | 27 | — | 27 |
Other | — | — | — | — | — | — | — |
Total Judgemental Adjustments | 25 | (5) | 19 | (11) | 33 | — | 61 |
Total ECL | 137 | 155 | 134 | 63 | 323 | — | 812 |
Total JAs as a percentage of Total ECL (%) | 8 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Upside | Base case | Downside 1 | Downside 2 | Weighted | |
30 June 2026 | £m | £m | £m | £m | £m |
Exposure | |||||
Retail & Business Banking | |||||
Of which: | |||||
– Mortgages | |||||
Consumer Finance | |||||
Corporate & Commercial Banking | |||||
Corporate Centre | |||||
ECL | |||||
Retail & Business Banking | |||||
Of which: | |||||
– Mortgages | |||||
Consumer Finance | |||||
Corporate & Commercial Banking | |||||
Corporate Centre | |||||
31 December 2025 | £m | £m | £m | £m | £m |
Exposure | |||||
Retail & Business Banking | |||||
Of which: | |||||
– Mortgages | |||||
Consumer Finance | |||||
Corporate & Commercial Banking | |||||
Corporate Centre | |||||
ECL | |||||
Retail & Business Banking | |||||
Of which: | |||||
– Mortgages | |||||
Consumer Finance | |||||
Corporate & Commercial Banking | |||||
Corporate Centre | |||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Santander UK risk grade | Loss allowance | Total | ||||||||
9 | 8 | 7 | 6 | 5 | 4 | 3 to 1 | Other1,2 | |||
30 June 2026 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
Exposures - On balance sheet | ||||||||||
Financial assets at amortised cost: | ||||||||||
–Loans and advances to customers2 | 10.6 | 31.6 | 84.9 | 71.7 | 23.0 | 7.0 | 5.4 | 7.0 | (0.8) | 240.4 |
–Stage 1 | 10.4 | 31.1 | 81.5 | 66.0 | 19.8 | 3.9 | 1.2 | 6.6 | (0.2) | 220.3 |
–Stage 2 | 0.2 | 0.5 | 3.4 | 5.7 | 3.2 | 3.1 | 2.1 | 0.2 | (0.3) | 18.1 |
–Stage 3 | — | — | — | — | — | — | 1.8 | 0.1 | (0.3) | 1.6 |
–POCI | — | — | — | — | — | — | 0.3 | 0.1 | — | 0.4 |
Of which mortgages: | 9.9 | 29.7 | 78.8 | 63.5 | 14.2 | 3.5 | 2.9 | 0.1 | (0.1) | 202.5 |
–Stage 1 | 9.8 | 29.2 | 75.5 | 57.8 | 11.5 | 1.2 | 0.3 | — | — | 185.3 |
–Stage 2 | 0.1 | 0.5 | 3.3 | 5.7 | 2.7 | 2.3 | 1.1 | — | (0.1) | 15.6 |
–Stage 3 | — | — | — | — | — | — | 1.2 | — | — | 1.2 |
–POCI | — | — | — | — | — | — | 0.3 | 0.1 | — | 0.4 |
Santander UK risk grade | Total | Coverage Ratio | ||||||||
9 | 8 | 7 | 6 | 5 | 4 | 3 to 1 | Other1,2 | |||
30 June 2026 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | % |
ECL - On balance sheet | ||||||||||
Financial assets at amortised cost: | ||||||||||
–Loans and advances to customers2 | — | — | — | 0.1 | 0.1 | 0.1 | 0.5 | — | 0.8 | 0.3 |
–Stage 1 | — | — | — | 0.1 | 0.1 | — | — | — | 0.2 | 0.1 |
–Stage 2 | — | — | — | — | — | 0.1 | 0.2 | — | 0.3 | 1.6 |
–Stage 3 | — | — | — | — | — | — | 0.3 | — | 0.3 | 15.8 |
Of which mortgages: | — | — | — | — | — | — | 0.1 | — | 0.1 | — |
–Stage 1 | — | — | — | — | — | — | — | — | — | — |
–Stage 2 | — | — | — | — | — | — | 0.1 | — | 0.1 | 0.6 |
–Stage 3 | — | — | — | — | — | — | — | — | — | — |
Santander UK risk grade | Loss allowance | |||||||||
9 | 8 | 7 | 6 | 5 | 4 | 3 to 1 | Other1,2 | Total | ||
31 December 2025 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
Exposures - On balance sheet | ||||||||||
Financial assets at amortised cost: | ||||||||||
–Loans and advances to customers2 | 11.2 | 31.6 | 80.9 | 46.1 | 15.4 | 6.2 | 5.0 | 6.9 | (0.7) | 202.6 |
–Stage 1 | 11.0 | 31.0 | 77.9 | 41.0 | 12.4 | 2.9 | 0.7 | 6.8 | (0.1) | 183.6 |
–Stage 2 | 0.2 | 0.6 | 3.0 | 5.1 | 3.0 | 3.3 | 2.1 | 0.1 | (0.3) | 17.1 |
–Stage 3 | — | — | — | — | — | — | 2.2 | — | (0.3) | 1.9 |
Of which mortgages: | 10.6 | 29.7 | 75.5 | 39.3 | 6.7 | 3.0 | 2.4 | 0.1 | (0.1) | 167.2 |
–Stage 1 | 10.4 | 29.1 | 72.4 | 34.3 | 4.3 | 0.4 | 0.1 | — | — | 151.0 |
–Stage 2 | 0.2 | 0.5 | 3.1 | 5.0 | 2.4 | 2.6 | 1.0 | — | — | 14.8 |
–Stage 3 | — | 0.1 | — | — | — | — | 1.3 | 0.1 | (0.1) | 1.4 |
Santander UK risk grade | Total | Coverage Ratio | ||||||||
9 | 8 | 7 | 6 | 5 | 4 | 3 to 1 | Other1,2 | |||
31 December 2025 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | % |
ECL - On balance sheet | ||||||||||
Financial assets at amortised cost: | ||||||||||
–Loans and advances to customers2 | — | — | — | — | 0.2 | 0.1 | 0.4 | — | 0.7 | 0.3 |
–Stage 1 | — | — | — | — | 0.1 | — | — | — | 0.1 | 0.1 |
–Stage 2 | — | — | — | — | 0.1 | 0.1 | 0.1 | — | 0.3 | 1.7 |
–Stage 3 | — | — | — | — | — | — | 0.3 | — | 0.3 | 13.6 |
Of which mortgages: | — | — | — | — | — | — | 0.1 | — | 0.1 | 0.1 |
–Stage 1 | — | — | — | — | — | — | — | — | — | — |
–Stage 2 | — | — | — | — | — | — | — | — | — | — |
–Stage 3 | — | — | — | — | — | — | 0.1 | — | 0.1 | 6.7 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Customer Loans | 6 month Gross write-offs | Loan Loss Allowance s | ||||||
Total | Stage 1 | Stage 2 | Stage 31 | POCI | ||||
30 June 2026 | £bn | £bn | £bn | £bn | % | £bn | £m | £m |
Retail & Business Banking | 210.8 | 192.4 | 16.7 | 1.3 | 0.65 | 0.4 | 93 | 440 |
– Mortgages | 202.6 | 185.2 | 15.8 | 1.2 | 0.59 | 0.4 | 10 | 135 |
– Credit Cards | 3.7 | 3.2 | 0.4 | 0.1 | 2.67 | — | 33 | 161 |
– Unsecured Personal Loans | 3.2 | 3.0 | 0.2 | — | 0.83 | — | 32 | 89 |
– Overdrafts | 0.5 | 0.3 | 0.2 | — | 5.67 | — | 15 | 39 |
– Business Banking | 0.8 | 0.7 | 0.1 | — | 4.06 | — | 3 | 16 |
Consumer Finance | 5.0 | 4.6 | 0.4 | — | 0.97 | — | 15 | 67 |
Corporate & Commercial Banking | 19.5 | 17.6 | 1.3 | 0.6 | 3.03 | — | 21 | 296 |
Corporate Centre | — | — | — | — | — | — | — | — |
Total Drawn | 235.3 | 214.6 | 18.4 | 1.9 | 0.86 | 0.4 | 129 | 803 |
Retail & Business Banking | 31.9 | 31.1 | 0.8 | — | — | — | 47 | |
– Mortgages | 14.9 | 14.7 | 0.2 | — | — | — | 1 | |
– Credit Cards | 13.1 | 12.8 | 0.3 | — | — | — | 19 | |
– Unsecured Personal Loans | — | — | — | — | — | — | — | |
– Overdrafts | 3.6 | 3.3 | 0.3 | — | — | — | 26 | |
– Business Banking | 0.3 | 0.3 | — | — | — | — | 1 | |
Consumer Finance | — | — | — | — | — | — | — | |
Corporate & Commercial Banking | 9.6 | 9.3 | 0.3 | — | — | — | 39 | |
Corporate Centre | 0.3 | 0.3 | — | — | — | — | — | |
Total Undrawn | 41.8 | 40.7 | 1.1 | — | — | — | 86 | |
Total | 277.1 | 255.3 | 19.5 | 1.9 | 0.4 | 129 | 889 | |
Customer Loans | 12 month Gross write- offs | Loan Loss Allowances | |||||
Total | Stage 1 | Stage 2 | Stage 31 | ||||
31 December 2025 | £bn | £bn | £bn | £bn | % | £m | £m |
Retail & Business Banking | 173.5 | 156.2 | 15.7 | 1.6 | 0.95 | 168 | 384 |
– Mortgages | 167.3 | 151.0 | 14.8 | 1.5 | 0.88 | 15 | 137 |
– Credit Cards | 3.1 | 2.6 | 0.4 | 0.1 | 2.88 | 55 | 137 |
– Unsecured Personal Loans | 2.0 | 1.8 | 0.2 | — | 1.07 | 65 | 57 |
– Overdrafts | 0.4 | 0.2 | 0.2 | — | 6.87 | 24 | 37 |
– Business Banking | 0.7 | 0.6 | 0.1 | — | 5.65 | 9 | 16 |
Consumer Finance | 5.0 | 4.6 | 0.4 | — | 0.96 | 27 | 63 |
Corporate & Commercial Banking | 18.9 | 16.9 | 1.4 | 0.6 | 3.42 | 53 | 282 |
Corporate Centre | — | — | — | — | 0.15 | — | — |
Total Drawn | 197.4 | 177.7 | 17.5 | 2.2 | 1.18 | 248 | 729 |
Retail & Business Banking | 27.8 | 27.0 | 0.8 | — | — | 42 | |
– Mortgages | 13.1 | 12.8 | 0.3 | — | — | — | |
– Credit Cards | 11.6 | 11.3 | 0.3 | — | — | 18 | |
– Unsecured Personal Loans | — | — | — | — | — | — | |
– Overdrafts | 2.9 | 2.7 | 0.2 | — | — | 23 | |
– Business Banking | 0.2 | 0.2 | — | — | — | 1 | |
Consumer Finance | — | — | — | — | — | — | |
Corporate & Commercial Banking | 8.4 | 8.1 | 0.3 | — | — | 41 | |
Corporate Centre | 2.6 | 2.6 | — | — | — | — | |
Total Undrawn | 38.8 | 37.7 | 1.1 | — | — | 83 | |
Total | 236.2 | 215.4 | 18.6 | 2.2 | 248 | 812 | |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | ||
% | % | ||
Retail & Business Banking | |||
–Mortgages | 0.54 | 0.65 | |
–Credit Cards | 0.80 | 0.55 | |
–Unsecured Personal Loans | 0.91 | 0.78 | |
–Overdrafts | 3.49 | 3.09 | |
–Business Banking | 2.91 | 3.83 | |
Consumer Finance | 0.43 | 0.44 | |
Corporate & Commercial Banking | 1.31 | 1.04 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stage 1 | Stage 2 | Stage 34 | POCI | Total | |
30 June 2026 | £m | £m | £m | £m | £m |
Exposures | |||||
On-balance sheet | |||||
Retail & Business Banking | 192,435 | 16,640 | 1,325 | 425 | 210,825 |
Consumer Finance | 4,534 | 406 | 48 | — | 4,988 |
Corporate & Commercial Banking | 17,617 | 1,311 | 564 | — | 19,492 |
Corporate Centre | 61,567 | — | — | — | 61,567 |
Total on-balance sheet | 276,153 | 18,357 | 1,937 | 425 | 296,872 |
Off–balance sheet | |||||
Retail & Business Banking1 | 31,027 | 768 | 52 | 28 | 31,875 |
Consumer Finance | — | — | — | — | — |
Corporate & Commercial Banking | 9,310 | 306 | 27 | — | 9,643 |
Corporate Centre | 279 | — | — | — | 279 |
Total off–balance sheet2 | 40,616 | 1,074 | 79 | 28 | 41,797 |
Total exposures | 316,769 | 19,431 | 2,016 | 453 | 338,669 |
ECL | |||||
On-balance sheet | |||||
Retail & Business Banking | 108 | 209 | 125 | (2) | 440 |
Consumer Finance | 13 | 26 | 28 | — | 67 |
Corporate & Commercial Banking | 54 | 52 | 190 | — | 296 |
Corporate Centre | — | — | — | — | — |
Total on-balance sheet | 175 | 287 | 343 | (2) | 803 |
Off–balance sheet | |||||
Retail & Business Banking | 15 | 31 | 1 | — | 47 |
Consumer Finance | — | — | — | — | — |
Corporate & Commercial Banking | 24 | 10 | 5 | — | 39 |
Corporate Centre | — | — | — | — | — |
Total off–balance sheet | 39 | 41 | 6 | — | 86 |
Total ECL | 214 | 328 | 349 | (2) | 889 |
Coverage ratio3 | % | % | % | % | % |
On-balance sheet | |||||
Retail & Business Banking | 0.1 | 1.3 | 9.5 | (0.5) | 0.2 |
Consumer Finance | 0.3 | 6.5 | 57.5 | — | 1.3 |
Corporate & Commercial Banking | 0.3 | 3.9 | 33.6 | — | 1.5 |
Corporate Centre | — | — | — | — | — |
Total on-balance sheet | 0.1 | 1.6 | 17.7 | (0.5) | 0.3 |
Off–balance sheet | |||||
Retail & Business Banking | — | 4.1 | 2.9 | 0.9 | 0.1 |
Consumer Finance | — | — | — | — | — |
Corporate & Commercial Banking | 0.3 | 3.1 | 18.4 | — | 0.4 |
Corporate Centre | — | — | — | — | — |
Total off-balance sheet | 0.1 | 3.8 | 8.2 | 0.9 | 0.2 |
Total coverage | 0.1 | 1.7 | 17.4 | (0.4) | 0.3 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stage 1 | Stage 2 | Stage 34 | Total | |
31 December 2025 | £m | £m | £m | £m |
Exposures | ||||
On-balance sheet | ||||
Retail & Business Banking | 156,212 | 15,657 | 1,592 | 173,461 |
Consumer Finance | 4,595 | 336 | 48 | 4,979 |
Corporate & Commercial Banking | 16,859 | 1,445 | 623 | 18,927 |
Corporate Centre | 57,305 | — | — | 57,305 |
Total on-balance sheet | 234,971 | 17,438 | 2,263 | 254,672 |
Off–balance sheet | ||||
Retail & Business Banking1 | 27,026 | 752 | 51 | 27,829 |
Consumer Finance | — | — | — | — |
Corporate & Commercial Banking | 8,074 | 334 | 26 | 8,434 |
Corporate Centre | 2,558 | — | — | 2,558 |
Total off–balance sheet2 | 37,658 | 1,086 | 77 | 38,821 |
Total exposures | 272,629 | 18,524 | 2,340 | 293,493 |
ECL | ||||
On-balance sheet | ||||
Retail & Business Banking | 54 | 207 | 123 | 384 |
Consumer Finance | 14 | 21 | 28 | 63 |
Corporate & Commercial Banking | 53 | 35 | 194 | 282 |
Corporate Centre | — | — | — | — |
Total on-balance sheet | 121 | 263 | 345 | 729 |
Off–balance sheet | ||||
Retail & Business Banking | 11 | 29 | 2 | 42 |
Consumer Finance | — | — | — | — |
Corporate & Commercial Banking | 25 | 9 | 7 | 41 |
Corporate Centre | — | — | — | — |
Total off–balance sheet | 36 | 38 | 9 | 83 |
Total ECL | 157 | 301 | 354 | 812 |
Coverage ratio3 | % | % | % | % |
On-balance sheet | ||||
Retail & Business Banking | — | 1.3 | 7.7 | 0.2 |
Consumer Finance | 0.3 | 6.2 | 58.4 | 1.3 |
Corporate & Commercial Banking | 0.3 | 2.4 | 31.1 | 1.5 |
Corporate Centre | — | — | — | — |
Total on-balance sheet | 0.1 | 1.5 | 15.2 | 0.3 |
Off–balance sheet | ||||
Retail & Business Banking | — | 3.9 | 2.7 | 0.1 |
Consumer Finance | — | — | — | — |
Corporate & Commercial Banking | 0.3 | 2.7 | 28.1 | 0.5 |
Corporate Centre | — | — | — | — |
Total off-balance sheet | 0.1 | 3.5 | 11.4 | 0.2 |
Total coverage | 0.1 | 1.6 | 15.1 | 0.3 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | Backstop | Quantitative | Qualitative | JAs | Total | |||
30 DPD | PD deterioration | PD threshold | Forbearance | Other1 | Mortgage Refinancing | |||
Retail & Business Banking | Exposure £m | 470 | 9,539 | 371 | 446 | 5,094 | 720 | 16,640 |
ECL £m | 20 | 119 | 26 | 6 | 34 | 4 | 209 | |
Of which -Mortgages | Exposure £m | 399 | 8,947 | 269 | 424 | 5,000 | 720 | 15,759 |
ECL £m | 5 | 39 | 3 | 3 | 14 | 4 | 68 | |
Consumer Finance | Exposure £m | 53 | 165 | 9 | 2 | 177 | — | 406 |
ECL £m | 12 | 6 | 4 | — | 4 | — | 26 | |
Corporate & Commercial Banking | Exposure £m | 16 | 707 | 134 | 53 | 401 | — | 1,311 |
ECL £m | 2 | 13 | 18 | 1 | 18 | — | 52 | |
Corporate Centre | Exposure £m | — | — | — | — | — | — | — |
ECL £m | — | — | — | — | — | — | — | |
Total Drawn | Exposure £m | 539 | 10,411 | 514 | 501 | 5,672 | 720 | 18,357 |
ECL £m | 34 | 138 | 48 | 7 | 56 | 4 | 287 | |
Undrawn | ECL £m | — | 26 | 5 | 1 | 9 | — | 41 |
Total Reported | Exposure £m | 552 | 11,072 | 558 | 549 | 5,980 | 720 | 19,431 |
ECL £m | 34 | 164 | 53 | 8 | 65 | 4 | 328 | |
31 December 2025 | Backstop | Quantitative | Qualitative | JAs | Total | |||
30 DPD | PD deterioration | PD threshold | Forbearance | Other1 | Mortgage Refinancing | |||
Retail & Business Banking | Exposure £m | 463 | 8,945 | 389 | 485 | 4,965 | 410 | 15,657 |
ECL £m | 17 | 120 | 27 | 5 | 36 | 2 | 207 | |
Of which -Mortgages | Exposure £m | 394 | 8,365 | 281 | 474 | 4,855 | 410 | 14,779 |
ECL £m | 5 | 40 | 3 | 3 | 16 | 2 | 69 | |
Consumer Finance | Exposure £m | 31 | 170 | 13 | 2 | 120 | — | 336 |
ECL £m | 8 | 8 | 4 | — | 1 | — | 21 | |
Corporate & Commercial Banking | Exposure £m | 92 | 771 | 90 | 22 | 470 | — | 1,445 |
ECL £m | — | 16 | 6 | — | 13 | — | 35 | |
Corporate Centre | Exposure £m | — | — | — | — | — | — | — |
ECL £m | — | — | — | — | — | — | — | |
Total Drawn | Exposure £m | 586 | 9,886 | 492 | 509 | 5,555 | 410 | 17,438 |
ECL £m | 25 | 144 | 37 | 5 | 50 | 2 | 263 | |
Undrawn | ECL £m | — | 23 | 6 | 1 | 8 | — | 38 |
Total Reported | Exposure £m | 616 | 10,504 | 536 | 551 | 5,907 | 410 | 18,524 |
ECL £m | 25 | 167 | 43 | 6 | 58 | 2 | 301 | |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
On-balance sheet | Off-balance sheet | |||||
Exposures | Loss allowance | Net carrying amount | Exposures | Loss allowance | ||
30 June 2026 | £m | £m | £m | £m | £m | |
Retail & Business Banking1 | 210,825 | 440 | 210,385 | 31,875 | 47 | |
Consumer Finance | 4,988 | 67 | 4,921 | — | — | |
Corporate & Commercial Banking | 19,492 | 296 | 19,196 | 9,643 | 39 | |
Corporate Centre | 61,567 | — | 61,567 | 279 | — | |
Total exposures presented in Credit Quality tables | 296,872 | 803 | 296,069 | 41,797 | 86 | |
Intercompany balances (including joint ventures) | 5,176 | |||||
Other items2 | 728 | |||||
Adjusted net carrying amount | 301,973 | |||||
Assets classified at FVTPL | 2,142 | |||||
Non-financial assets3 | 8,160 | |||||
Total assets per the Consolidated Balance Sheet | 312,275 | |||||
31 December 2025 | ||||||
Retail & Business Banking1 | 173,461 | 384 | 173,077 | 27,829 | 42 | |
Consumer Finance | 4,979 | 63 | 4,916 | — | — | |
Corporate & Commercial Banking | 18,927 | 282 | 18,645 | 8,434 | 41 | |
Corporate Centre | 57,305 | — | 57,305 | 2,558 | — | |
Total exposures presented in Credit Quality tables | 254,672 | 729 | 253,943 | 38,821 | 83 | |
Intercompany balances (including joint ventures) | 5,055 | |||||
Other items2 | 916 | |||||
Adjusted net carrying amount | 259,914 | |||||
Assets classified at FVTPL | 934 | |||||
Non-financial assets3 | 5,989 | |||||
Total assets per the Consolidated Balance Sheet | 266,837 | |||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stage 1 | Stage 2 | Stage 3 | POCI | Total | ||||||
Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2026 | ||||||||||
Transfers from Stage 1 to Stage 22 | ( | ( | ||||||||
Transfers from Stage 2 to Stage 12 | ( | ( | ||||||||
Transfers to Stage 32 | ( | ( | ( | ( | ||||||
Transfers from Stage 32 | ( | ( | ||||||||
Transfers of financial instruments | ( | ( | ||||||||
Net ECL remeasurement on stage transfer3 | ( | |||||||||
Change in economic scenarios4 | ||||||||||
Change to ECL models | ||||||||||
Acquisition of TSB | ||||||||||
New lending and assets purchased5, 8 | ||||||||||
Redemptions, repayments and assets sold6, 8 | ( | ( | ( | ( | ( | ( | ( | ( | ( | |
Changes in risk parameters and other movements7 | ( | ( | ( | ( | ||||||
Assets written off6 | ( | ( | ( | ( | ( | ( | ||||
At 30 June 2026 | ( | |||||||||
Net movement in the period | ( | ( | ( | |||||||
ECL charge to the Income Statement | ||||||||||
Less: Discount unwind | ( | ( | ||||||||
Less: Recoveries net of collection costs | ( | |||||||||
Total ECL charge to the Income Statement | ||||||||||
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | |
£m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2025 | ||||||||
Transfers from Stage 1 to Stage 22 | ( | ( | ||||||
Transfers from Stage 2 to Stage 12 | ( | ( | ||||||
Transfers to Stage 32 | ( | ( | ( | ( | ||||
Transfers from Stage 32 | ( | ( | ||||||
Transfers of financial instruments | ( | ( | ( | ( | ||||
Net ECL remeasurement on stage transfer3 | ( | |||||||
Change in economic scenarios4 | ( | ( | ( | |||||
Change to ECL models | ||||||||
New lending and assets purchased5 8 | ||||||||
Redemptions, repayments and assets sold6 8 | ( | ( | ( | ( | ( | ( | ( | ( |
Changes in risk parameters and other movements7 | ( | ( | ( | ( | ||||
Assets written off6 | ( | ( | ( | ( | ||||
At 30 June 2025 | ||||||||
Net movement in the period | ( | ( | ( | ( | ||||
ECL (release)/charge to the Income Statement | ( | ( | ||||||
Less: Discount unwind | ( | ( | ||||||
Less: Recoveries net of collection costs | ||||||||
Total ECL (release)/charge to the Income Statement | ( | ( | ||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stock | New business | ||||||||
30 June 2026 | 31 December 2025 | 30 June 2026 | 30 June 2025 | ||||||
£m | % | £m | % | £m | % | £m | % | ||
Home movers1 | 81,411 | 40 | 69,963 | 42 | 6,369 | 44 | 4,192 | 39 | |
Remortgagers2 | 62,797 | 31 | 47,242 | 28 | 6,020 | 41 | 3,909 | 37 | |
First-time buyers | 39,654 | 20 | 34,776 | 21 | 1,659 | 11 | 1,613 | 15 | |
Buy-to-let | 18,782 | 9 | 15,287 | 9 | 613 | 4 | 906 | 9 | |
202,644 | 100 | 167,268 | 100 | 14,661 | 100 | 10,620 | 100 | ||
Movement in mortgage lending | £bn |
1 January 2026 | 167.3 |
New business | 14.7 |
Acquisition of TSB | 33.9 |
Redemptions and repayments | (13.3) |
30 June 2026 | 202.6 |
30 June 2026 | 31 December 2025 | ||
Proportion of Santander-branded mortgage internal transfers retained online | 83% | 79% |
30 June 2026 | 30 June 2025 | ||
Internal transfers (£bn)3 | 18.4 | 14.9 | |
Further advances and flexi drawdowns (£bn) | 0.5 | 0.5 |
30 June 2026 | 31 December 2025 | ||||
£m | % | £m | % | ||
Fixed rate | 185,682 | 91 | 153,172 | 92 | |
Of which maturing: | |||||
–< 12 months | 59,875 | 29 | 41,262 | 25 | |
–Later than 1 year but no later than 3 years | 89,950 | 44 | 83,529 | 50 | |
–Later than 3 years but no later than 4 years | 13,261 | 7 | 11,431 | 7 | |
–Later than 4 years but no later than 5 years | 19,569 | 10 | 14,011 | 8 | |
–Later than 5 years | 3,027 | 1 | 2,939 | 2 | |
Variable rate | 11,961 | 6 | 10,227 | 6 | |
Standard Variable Rate (SVR) | 3,783 | 2 | 2,434 | 1 | |
Follow on Rate (FoR) | 1,218 | 1 | 1,435 | 1 | |
202,644 | 100 | 167,268 | 100 | ||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stock | New business | ||||
30 June 2026 | 31 December 2025 | 30 June 2026 | 30 June 2025 | ||
Region | £bn | £bn | £bn | £bn | |
London | 49.3 | 43.9 | 3.2 | 3.1 | |
Midlands and East Anglia | 29.6 | 23.4 | 2.3 | 1.4 | |
North | 28.9 | 21.8 | 2.2 | 1.3 | |
Northern Ireland | 2.1 | 2.2 | 0.1 | 0.1 | |
Scotland | 9.9 | 6.0 | 0.7 | 0.4 | |
South East excluding London | 60.9 | 52.7 | 4.6 | 3.3 | |
South West, Wales and other | 21.9 | 17.3 | 1.6 | 1.0 | |
202.6 | 167.3 | 14.7 | 10.6 | ||
Mortgage loan size | 30 June 2026 | 31 December 2025 | |
>£1.0m | 3% | 3% | |
£0.5m to £1.0m | 10% | 11% | |
£0.25m to £0.5m | 32% | 32% | |
<£0.25m | 55% | 54% | |
Average loan size (stock)1 | £200k | £201k | |
Average loan size (new business) | £249k | £254k |
30 June 2026 | 31 December 2025 | 30 June 2025 | |||||||||
Stock | Stage 3 | New Business | Stock | Stage 3 | New Business | ||||||
Total | ECL | Total | ECL | Total | ECL | Total | ECL | ||||
LTV | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Up to 50% | 87,087 | 26 | 545 | 8 | 2,930 | 75,743 | 29 | 705 | 10 | 2,548 | |
>50-60% | 38,488 | 18 | 230 | 4 | 2,412 | 33,122 | 17 | 270 | 6 | 2,020 | |
>60-70% | 32,962 | 20 | 180 | 6 | 2,261 | 27,776 | 21 | 210 | 9 | 1,664 | |
>70-80% | 25,185 | 21 | 101 | 6 | 2,881 | 18,466 | 19 | 122 | 7 | 2,192 | |
>80-90% | 15,091 | 17 | 51 | 6 | 2,712 | 9,385 | 15 | 64 | 7 | 1,526 | |
>90-100% | 3,594 | 11 | 28 | 4 | 1,456 | 2,503 | 10 | 30 | 4 | 662 | |
>100% | 237 | 23 | 40 | 13 | 9 | 273 | 26 | 49 | 14 | 8 | |
202,644 | 136 | 1,175 | 47 | 14,661 | 167,268 | 137 | 1,450 | 57 | 10,620 | ||
Collateral value1 | 202,609 | 1,168 | 14,661 | 167,234 | 1,441 | 10,620 | |||||
% | % | % | % | % | % | ||||||
Average balance weighted LTV2 | 53 | 53 | 66 | 52 | 52 | 63 | |||||
Of which: | |||||||||||
London lending (new business) | 64 | 62 | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Stage 1 | Stage 2 | Stage 3 | POCI | Total | ||||||
Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | Exposures1 | ECL | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2026 | 163,834 | 11 | 15,041 | 69 | 1,464 | 57 | — | — | 180,339 | 137 |
Transfers from Stage 1 to Stage 22 | (5,878) | (3) | 5,878 | 3 | — | — | — | — | — | — |
Transfers from Stage 2 to Stage 12 | 2,951 | 11 | (2,951) | (11) | — | — | — | — | — | — |
Transfers to Stage 32 | (69) | — | (268) | (3) | 337 | 3 | — | — | — | — |
Transfers from Stage 32 | — | — | 135 | 3 | (135) | (3) | — | — | — | — |
Transfers of financial instruments | (2,996) | 8 | 2,794 | (8) | 202 | — | — | — | — | — |
Net ECL remeasurement on stage transfer3 | — | (11) | — | 13 | — | 4 | — | — | — | 6 |
Change in economic scenarios4 | — | 1 | — | — | — | 1 | — | — | — | 2 |
Change to ECL models | — | — | — | — | — | — | — | — | — | — |
Acquisition of TSB | 35,426 | 11 | — | — | — | — | 408 | — | 35,834 | 11 |
New lending and assets purchased5 8 | 23,197 | 5 | 173 | 2 | 21 | 1 | — | — | 23,391 | 8 |
Redemptions, repayments and assets sold6 8 | (12,801) | (1) | (1,974) | (13) | (470) | (14) | (7) | — | (15,252) | (28) |
Changes in risk parameters and other movements7 | (6,729) | (3) | (53) | 5 | 13 | 7 | (4) | 1 | (6,773) | 10 |
Assets written off6 | — | — | — | — | (42) | (9) | (1) | (1) | (43) | (10) |
At 30 June 2026 | 199,931 | 21 | 15,981 | 68 | 1,188 | 47 | 396 | — | 217,496 | 136 |
Net movement in the period | 36,097 | 10 | 940 | (1) | (276) | (10) | 396 | — | 37,157 | (1) |
ECL charge/(release) to the Income Statement | 10 | (1) | (1) | 1 | 9 | |||||
Less: Discount unwind | — | — | (1) | — | (1) | |||||
Less: Recoveries net of collection costs | — | — | 81 | — | 81 | |||||
Total ECL charge/(release) to the Income Statement | 10 | (1) | 79 | 1 | 89 | |||||
At 1 January 2025 | 157,268 | 10 | 16,973 | 84 | 1,785 | 78 | — | — | 176,026 | 172 |
Transfers from Stage 1 to Stage 22 | (3,908) | — | 3,908 | — | — | — | — | — | — | — |
Transfers from Stage 2 to Stage 12 | 3,902 | 10 | (3,902) | (10) | — | — | — | — | — | — |
Transfers to Stage 32 | (54) | — | (339) | (4) | 393 | 4 | — | — | — | — |
Transfers from Stage 32 | — | — | 276 | 8 | (276) | (8) | — | — | — | — |
Transfers of financial instruments | (60) | 10 | (57) | (6) | 117 | (4) | — | — | — | — |
Net ECL remeasurement on stage transfer3 | — | (9) | — | 7 | — | 6 | — | — | — | 4 |
Change in economic scenarios4 | — | (5) | — | (5) | — | (4) | — | — | — | (14) |
Change to ECL models | — | — | — | — | — | — | — | — | — | — |
New lending and assets purchased5 8 | 19,002 | 3 | 119 | 2 | 18 | 1 | — | — | 19,139 | 6 |
Redemptions, repayments and assets sold6 8 | (10,407) | — | (1,247) | (4) | (243) | (7) | — | — | (11,897) | (11) |
Changes in risk parameters and other movements7 | (4,700) | — | 28 | 1 | 15 | 7 | — | — | (4,657) | 8 |
Assets written off6 | — | — | — | — | (27) | (7) | — | — | (27) | (7) |
At 30 June 2025 | 161,103 | 9 | 15,816 | 79 | 1,665 | 70 | — | — | 178,584 | 158 |
Net movement in the period | 3,835 | (1) | (1,157) | (5) | (120) | (8) | — | — | 2,558 | (14) |
ECL release to the Income Statement | (1) | (5) | (1) | — | (7) | |||||
Less: Discount unwind | — | — | (1) | — | (1) | |||||
Less: Recoveries net of collection costs | — | — | 10 | — | 10 | |||||
Total ECL (release)/charge to the Income Statement | (1) | (5) | 8 | — | 2 | |||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Total | Stage 1 | Stage 2 | Stage 3 | Stage 3 ratio | POCI | Properties in possession | Balance weighted LTV (indexed) | |
30 June 2026 | £m | £m | £m | £m | % | £m | £m | % |
Mortgage portfolio | 202,644 | 185,314 | 15,759 | 1,175 | 0.59 | 396 | 62 | 53 |
Of which: Portfolio of particular interest1 | ||||||||
– Interest only | 39,804 | 33,608 | 5,557 | 492 | 1.24 | 147 | 23 | 45 |
– Part interest-only, part repayment2 | 11,253 | 9,773 | 1,359 | 121 | 1.08 | — | 8 | 53 |
– Flexible | 3,172 | 2,252 | 776 | 144 | 4.54 | — | 9 | 37 |
– LTV >100% | 237 | 69 | 124 | 40 | 16.88 | 4 | 15 | 111 |
– Buy-to-let | 18,782 | 17,386 | 1,305 | 52 | 0.28 | 39 | 3 | 52 |
– Whistletree | 463 | 356 | 33 | 2 | 0.43 | 72 | — | 41 |
31 December 2025 | ||||||||
Mortgage portfolio | 167,268 | 151,039 | 14,779 | 1,450 | 0.88 | 74 | 52 | |
Of which: Portfolio of particular interest1 | ||||||||
– Interest only | 35,637 | 29,866 | 5,155 | 616 | 1.74 | 35 | 49 | |
– Part interest-only, part repayment2 | 11,495 | 9,978 | 1,357 | 160 | 1.40 | 9 | 53 | |
– Flexible | 3,504 | 2,508 | 828 | 168 | 5.19 | 11 | 37 | |
– LTV >100% | 273 | 88 | 136 | 49 | 17.91 | 18 | 116 | |
– Buy-to-let | 15,287 | 14,166 | 1,070 | 51 | 0.33 | 4 | 59 | |
30 June 2026 | 31 December 2025 | ||
BBLS with 100% Government Guarantee (£bn) | 0.5 | 0.6 | |
% of credit card customers that repay balance in full each month | 53% | 54% | |
UPL average customer balance (£) | 6,000 | 6,000 |
30 June 2026 | 31 December 2025 | ||
Wholesale loans (stock finance) to car dealerships as approximate % of the Consumer loan book | 11.6% | 13.8% | |
% of lending collateralised on the vehicle | 99% | 98% | |
Average Consumer (auto) finance loan size (£) | 21,603 | 19,551 |
30 June 2026 | 30 June 2025 | ||
Consumer (auto) finance new business gross lending (£m) | 1,153 | 1,034 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Santander UK risk grade | |||||||||
9 | 8 | 7 | 6 | 5 | 4 | 3 to 1 | Other | Total1 | |
30 June 2026 | £m | £m | £m | £m | £m | £m | £m | £m | £m |
SME and mid corporate | — | 344 | 1,169 | 3,810 | 4,505 | 2,917 | 1,357 | 40 | 14,142 |
Commercial Real Estate | — | 1 | 898 | 3,273 | 2,028 | 280 | 122 | — | 6,602 |
Social Housing | 137 | 2,248 | 5,967 | — | — | — | — | — | 8,352 |
137 | 2,593 | 8,034 | 7,083 | 6,533 | 3,197 | 1,479 | 40 | 29,096 | |
Of which: | |||||||||
–Stage 1 | 137 | 2,590 | 8,026 | 7,039 | 6,147 | 2,466 | 443 | 40 | 26,888 |
–Stage 2 | — | 3 | 8 | 44 | 386 | 731 | 445 | — | 1,617 |
–Stage 3 | — | — | — | — | — | — | 591 | — | 591 |
31 December 2025 | |||||||||
SME and mid corporate | — | 449 | 903 | 3,364 | 4,172 | 3,069 | 1,604 | 36 | 13,597 |
Commercial Real Estate | — | — | 802 | 2,589 | 2,360 | 411 | 134 | — | 6,296 |
Social Housing | 120 | 2,032 | 5,581 | — | — | — | — | — | 7,733 |
120 | 2,481 | 7,286 | 5,953 | 6,532 | 3,480 | 1,738 | 36 | 27,626 | |
Of which: | |||||||||
–Stage 1 | 120 | 2,481 | 7,278 | 5,910 | 6,219 | 2,710 | 444 | 36 | 25,198 |
–Stage 2 | — | — | 8 | 43 | 313 | 770 | 645 | — | 1,779 |
–Stage 3 | — | — | — | — | — | — | 649 | — | 649 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Liquidity risk is the risk that we do not have sufficient liquid financial resources available to meet our obligations as they fall due, or we can only secure such resources at high cost. Liquidity risk management In H1-26, there were no significant changes in the way we manage liquidity risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Liquidity risk review In this section, we analyse our key liquidity metrics and our wholesale funding. We also provide information on asset encumbrance. | Key metrics LCR of 163% (2025: 162%) LCR eligible liquidity pool of £54.6bn (2025: £47.5bn) NSFR of 137% (2025: 135%) Wholesale funding with maturity <1 year £20.1bn (2025: £13.1bn) |
30 June 2026 | 31 December 2025 | ||
LCR2 | £bn | £bn | |
Eligible liquidity pool (liquidity value)1 | 54.2 | 46.9 | |
Net stress outflows | (33.2) | (29.0) | |
Surplus | 21.0 | 17.9 | |
Eligible liquidity pool as a percentage of anticipated net cash flows | 163% | 162% |
30 June 2026 | 31 December 2025 | ||
% | % | ||
NSFR | 137 | 135 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
≤ 1 month | >1 and ≤ 3 months | >3 and ≤ 6 months | >6 and ≤ 9 months | >9 and ≤ 12 months | Sub-total ≤ 1 year | >1 and ≤ 2 years | >2 and ≤ 5 years | >5 years | Total | |
30 June 2026 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
Downstreamed from Santander UK Group Holdings plc to Santander UK plc1 | ||||||||||
Senior unsecured | — | — | 0.8 | 0.8 | — | 1.6 | 2.8 | 5.5 | 1.3 | 11.2 |
Subordinated liabilities and equity (incl. AT1) | — | — | — | — | 0.8 | 0.8 | 0.2 | 2.2 | 0.6 | 3.8 |
— | — | 0.8 | 0.8 | 0.8 | 2.4 | 3.0 | 7.7 | 1.9 | 15.0 | |
Other Santander UK plc | ||||||||||
Deposits by banks | 0.6 | 0.5 | 0.2 | — | — | 1.3 | — | — | — | 1.3 |
Certificates of deposit and commercial paper | 1.4 | 2.9 | — | — | 0.1 | 4.4 | 0.4 | — | — | 4.8 |
Senior unsecured | — | — | 0.1 | 0.5 | — | 0.6 | 0.9 | 1.7 | 0.2 | 3.4 |
Covered bonds | — | 0.2 | 0.1 | 3.6 | 0.6 | 4.5 | 4.6 | 7.4 | 1.6 | 18.1 |
Securitisation & structured issuance2 | 0.2 | 0.5 | 1.0 | 0.3 | 0.4 | 2.4 | 2.2 | 2.9 | — | 7.5 |
Of which: | ||||||||||
– RMBS and ABS | 0.2 | — | 0.2 | 0.3 | 0.4 | 1.1 | 2.2 | 2.9 | — | 6.2 |
TFSME | — | — | — | 2.5 | — | 2.5 | — | 1.4 | — | 3.9 |
Subordinated liabilities | — | — | — | — | — | — | — | 0.2 | 0.5 | 0.7 |
2.2 | 4.1 | 1.4 | 6.9 | 1.1 | 15.7 | 8.1 | 13.6 | 2.3 | 39.7 | |
Other group entities | ||||||||||
Senior unsecured | — | — | — | — | — | — | — | — | — | — |
Covered bonds | — | — | — | 1.0 | — | 1.0 | 0.5 | 2.2 | — | 3.7 |
Securitisation & structured issuance3 | — | 0.6 | — | — | — | 0.6 | — | 0.4 | — | 1.0 |
TFSME | — | — | — | 0.4 | — | 0.4 | — | 0.2 | — | 0.6 |
Total at 30 June 2026 | 2.2 | 4.7 | 2.2 | 9.1 | 1.9 | 20.1 | 11.6 | 24.1 | 4.2 | 60.0 |
Of which: | ||||||||||
– Secured | 0.3 | 1.3 | 1.1 | 7.8 | 1.0 | 11.5 | 7.2 | 14.5 | 1.5 | 34.7 |
– Unsecured | 1.9 | 3.4 | 1.1 | 1.3 | 0.9 | 8.6 | 4.4 | 9.6 | 2.7 | 25.3 |
Total at 31 December 2025 | 1.0 | 6.6 | 3.3 | 0.8 | 1.4 | 13.1 | 13.8 | 20.4 | 5.0 | 52.3 |
Of which: | ||||||||||
– Secured | — | 3.3 | 2.0 | 0.4 | 0.3 | 6.0 | 10.2 | 10.3 | 3.0 | 29.5 |
– Unsecured | 1.0 | 3.3 | 1.3 | 0.4 | 1.1 | 7.1 | 3.6 | 10.1 | 2.0 | 22.8 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Sterling | US Dollar | Euro | Other | Total H1-26 | Total H1-25 | ||
£bn | £bn | £bn | £bn | £bn | £bn | ||
Downstreamed from Santander UK Group Holdings plc to Santander UK plc | |||||||
Senior unsecured | — | — | 1.5 | — | 1.5 | 1.0 | |
Subordinated liabilities and equity (inc. AT1) | 1.0 | — | — | — | 1.0 | 0.5 | |
1.0 | — | 1.5 | — | 2.5 | 1.5 | ||
Other Santander UK plc | |||||||
Securitisations and other secured funding | 1.3 | — | — | — | 1.3 | 1.0 | |
Of which: | |||||||
– RMBS and ABS | 1.3 | — | — | — | 1.3 | 1.0 | |
Covered bonds | 0.7 | — | 2.0 | — | 2.7 | 2.7 | |
Senior unsecured | 0.1 | — | — | — | 0.1 | 1.9 | |
2.1 | — | 2.0 | — | 4.1 | 5.6 | ||
Other group entities | |||||||
Securitisations | — | — | — | — | — | — | |
Total gross issuances | 3.1 | — | 3.5 | — | 6.6 | 7.1 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Capital risk is the risk that we do not have an adequate amount or quality of capital to meet our internal business objectives, regulatory requirements and market expectations. Capital risk management In H1-26, there were no significant changes in the way we manage capital risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Capital risk review In this section, we analyse our capital resources and key capital ratios. | Key metrics CET1 capital ratio of 14.2% (2025: 15.8%) Total qualifying regulatory capital of £15.8bn (2025: £14.3bn) |
30 June 2026 | 31 December 2025 | ||
% | % | ||
CET1 capital ratio | 14.2 | 15.8 | |
AT1 | 2.6 | 2.8 | |
Tier 2 | 3.0 | 2.7 | |
Total capital ratio | 19.8 | 21.3 | |
Total subordination available to Santander UK plc senior unsecured bondholders as a % of RWAs | 19.8 | 21.3 | |
30 June 2026 | 30 June 2025 | ||
Return on assets - profit after tax divided by average total assets | 0.13 | 0.20 |
30 June 2026 | 31 December 2025 | ||
£m | £m | ||
CET1 capital | |||
AT1 capital | |||
Tier 1 capital | |||
Tier 2 capital | |||
Total capital1 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Market risk comprises banking market risk and trading market risk. Market risk management In H1-26, there were no significant changes in the way we manage market risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Market risk review In this section, we analyse our key banking and trading market risk metrics. | Key metrics Net Interest Income (NII) sensitivity to +100bps was £365m and to ‑100bps was £(256)m (2025: £281m and £(195)m). Economic Value of Equity (EVE) sensitivity to +100bps was £(646)m and to ‑100bps was £705m (2025: £(449)m and £540m). |
30 June 2026 | 31 December 2025 | ||||
+100bps | -100bps | +100bps | -100bps | ||
£m | £m | £m | £m | ||
NII sensitivity1 | ( | ( | |||
EVE sensitivity | (646) | 705 | (449) | 540 | |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Pension risk is the risk caused by our statutory contractual or other liabilities with respect to a pension scheme (whether set up for our employees or those of a related company or otherwise). It also refers to the risk that we will need to make payments or other contributions with respect to a pension scheme due to some other reason. Pension risk management In H1-26, there were no significant changes in the way we manage pension risk as described in the 2025 Annual Report. Pension risk review In this section, we give an update on key movements in pension risk profile in H1-26. | Key metrics Funding Deficit at Risk was £630m (2025: £760m) Funded defined benefit pension scheme accounting surplus was £560m (2025: £524m) |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Strategic and business risk is the risk of loss or underperformance against planned objectives; damage arising from strategic decisions or their poor implementation that impact the long-term interests of our key stakeholders; or from an inability to adapt to external developments. Strategic and business risk management In H1-26, there were no significant changes in the way we manage strategic and business risk, as described in the 2025 Annual Report, including as a result of the TSB acquisition. Strategic and business risk review In this section, we provide an update on key movements in strategic and business risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Reputational risk is the risk of damage to the way our reputation and brand are perceived by the public, clients, government, colleagues, investors, or any other interested party. Reputational risk management In H1-26, there were no significant changes in the way we manage reputational risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Reputational risk review In this section, we provide an update on key movements in reputational risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Operational risk is the risk of loss due to inadequate or failed internal processes, people and systems, or external events. Operational risk management In H1-26, there were no significant changes in the way we manage operational risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Operational risk review In this section, we give an update on key movements in operational risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Economic crime risk consists of Financial Crime (FC) risk and Fraud risk. FC risk is the risk that we are used to further FC, including money laundering, terrorist financing, sanctions evasion, bribery and corruption, and the facilitation of tax evasion. Fraud risk is the risk associated with attempted or successful fraud being committed against Santander UK, a customer or a third party. Economic crime risk management In H1-26, there were no significant changes in the way we manage economic crime risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Economic crime risk review In this section, we give an update on key developments in economic crime risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview Model risk is the risk that the predictions from models may be inaccurate, causing sub-optimal decisions to be made; or that a model may be used inappropriately. These potential adverse consequences can lead to reputational damage, regulatory non-compliance, a deterioration in prudential position, or financial losses. Model risk management In H1-26, there were no significant changes in the way we manage model risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Model risk review In this section, we give an update on key developments in model risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Overview We manage the compliance risk types in one framework. Compliance risk also includes data privacy and people risk. Compliance risk management In H1-26, there were no significant changes in the way we manage compliance risk as described in the 2025 Annual Report, including as a result of the TSB acquisition. Compliance risk review In this section, we give an update on key developments in compliance risk in H1-26. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Financial statements | ||||
Contents | ||||
Primary financial statements | 46 | |||
Condensed Consolidated Income Statement | 46 | |||
Condensed Consolidated Statement of Comprehensive Income | 47 | |||
Condensed Consolidated Balance Sheet | 48 | |||
Condensed Consolidated Cash Flow Statement | 49 | |||
Condensed Consolidated Statement of Changes in Equity | 50 | |||
Notes to the financial statements | 51 | |||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 30 June 2025 | ||
Notes | £m | £m | |
Interest and similar income | |||
Interest expense and similar charges | ( | ( | |
Net interest income | |||
Fee and commission income | |||
Fee and commission expense | ( | ( | |
Net fee and commission income | |||
Other operating income | |||
Regulatory fees and levies1 | ( | ( | |
Net operating income1 | |||
Operating expenses before credit impairment charges, restructuring and specific provisions1 | 3 | ( | ( |
Credit impairment charges | 4 | ( | ( |
Restructuring and specific provisions1 | 21 | ( | ( |
Total credit impairment charges, restructuring and specific provisions | 4 | ( | ( |
Profit before tax | |||
Tax on profit | 5 | ( | ( |
Profit after tax |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 30 June 2025 | ||
Notes | £m | £m | |
Profit after tax | |||
Other comprehensive (expense)/income that may be reclassified to profit or loss subsequently: | |||
Movement in fair value reserve (debt instruments): | |||
- Change in fair value | ( | ||
- Income statement transfers | ( | ||
- Taxation | ( | ( | |
0 | |||
Cash flow hedges: | |||
- Effective portion of changes in fair value | ( | ( | |
- Income statement transfers | |||
- Taxation | ( | ||
0 | ( | ||
Cost of hedging: | |||
- Cost of hedging gains | |||
Net other comprehensive (expense)/income that may be reclassified to profit or loss subsequently | ( | ||
Other comprehensive (expense)/income that will not be reclassified to profit or loss subsequently: | |||
Pension remeasurement: | |||
- Remeasurements of the net defined benefit (asset)/liability | 22 | ( | |
- Taxation | ( | ||
0 | ( | ||
Own credit adjustment: | |||
- Change in fair value | ( | ||
- Taxation | ( | ||
0 | ( | ||
Net other comprehensive (expense)/income that will not be reclassified to profit or loss subsequently | ( | ||
Total other comprehensive (expense)/income net of tax | ( | ||
Total comprehensive income |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | ||
Notes | £m | £m | |
Assets | |||
Cash and balances at central banks | |||
Derivative financial instruments | 7 | ||
Other financial assets at fair value through profit or loss | 8 | ||
Loans and advances to banks | |||
Loans and advances to customers | 9 | ||
Reverse repurchase agreements - non-trading | 11 | ||
Other financial assets at amortised cost | 12 | ||
Macro hedge of interest rate risk | ( | ( | |
Financial assets at fair value through other comprehensive income | |||
Interests in other entities | |||
Intangible assets | 14 | ||
Property, plant and equipment | 15 | ||
Current tax assets | |||
Retirement benefit assets | 22 | ||
Other assets | |||
Assets held for sale | |||
Total assets | |||
Liabilities | |||
Deposits by banks | 16 | ||
Deposits by customers | 17 | ||
Repurchase agreements - non-trading | 18 | ||
Derivative financial instruments | 7 | ||
Other financial liabilities at fair value through profit or loss | 19 | ||
Debt securities in issue | 20 | ||
Macro hedge of interest rate risk | |||
Other liabilities | |||
Provisions | 21 | ||
Deferred tax liabilities | |||
Retirement benefit obligations | 22 | ||
Subordinated liabilities | 23 | ||
Total liabilities | |||
Equity | |||
Share capital | |||
Share premium | |||
Other equity instruments | 25 | ||
Other reserves | ( | ||
Retained earnings | |||
Total equity | |||
Total liabilities and equity |
Mahesh Aditya | Angel Santodomingo |
Chief Executive Officer | Chief Financial Officer |
Company Registered Number: 02294747 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 30 June 2025 | ||
Notes | £m | £m | |
Cash flows from operating activities | |||
Profit before tax | |||
Adjustments for: | |||
Non-cash items included in profit | |||
Change in operating assets | ( | ||
Change in operating liabilities | ( | ( | |
Corporation taxes paid | ( | ( | |
Effects of exchange rate differences | ( | ( | |
Net cash flows from operating activities | ( | ||
Cash flows from investing activities | |||
Purchase of property, plant and equipment and intangible assets | ( | ( | |
Proceeds from sale of property, plant and equipment and intangible assets | |||
Purchase of financial assets at amortised cost and financial assets at FVOCI | ( | ( | |
Proceeds from sale and redemption of financial assets at amortised cost and financial assets at FVOCI | |||
Net cash flow from acquisition of TSB Banking Group plc | ( | ||
Net cash flows from investing activities | ( | ||
Cash flows from financing activities | |||
Issue of ordinary share capital | |||
Issue of other equity instruments | |||
Issue of debt securities and subordinated notes | |||
Issuance costs of debt securities and subordinated notes | ( | ( | |
Repayment of debt securities and subordinated notes | ( | ( | |
Repurchase of other equity instruments | ( | ( | |
Dividends paid on preference shares and other equity instruments | ( | ( | |
Principal elements of lease payments | ( | ( | |
Net cash flows from financing activities | |||
Change in cash and cash equivalents | |||
Cash and cash equivalents at beginning of the year | |||
Effects of exchange rate changes on cash and cash equivalents | ( | ||
Cash and cash equivalents at the end of the period | |||
Cash and cash equivalents consist of: | |||
Cash and balances at central banks | |||
Less: restricted balances | ( | ( | |
Other cash equivalents: Loans and advances to banks - non-trading | |||
Cash and cash equivalents at the end of the period |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Other reserves | ||||||||||
Share capital | Share premium | Other equity instruments | Capital contribution reserve | Fair value | Cash flow hedging | Cost of hedging | Currency translation | Retained earnings | ||
Total | ||||||||||
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2026 | ( | ( | ||||||||
Profit after tax | – | – | – | – | – | – | – | – | ||
Other comprehensive income/(expense), net of tax: | ||||||||||
- Fair value reserve (debt instruments) | – | – | – | – | – | – | – | – | ||
- Cash flow hedges | – | – | – | – | – | ( | – | – | – | ( |
- Cost of hedging | – | – | – | – | – | – | – | – | ||
- Pension remeasurement | – | – | – | – | – | – | – | – | ( | ( |
- Own credit adjustment | – | – | – | – | – | – | – | – | ( | ( |
Total other comprehensive income/(expense) | – | – | – | – | ( | – | ( | ( | ||
Total comprehensive income/(expense) | – | – | – | – | ( | – | ||||
Issue of ordinary shares | – | – | – | – | – | – | – | – | ||
Issue of other equity instruments | – | – | – | – | – | – | – | – | ||
Repurchase of other equity instruments | – | – | ( | – | – | – | – | – | – | ( |
Dividends on preference shares and other equity instruments | – | – | – | – | – | – | – | – | ( | ( |
At 30 June 2026 | ( | ( | ||||||||
At 1 January 2025 | ( | ( | ||||||||
Profit after tax | – | – | – | – | – | – | – | – | ||
Other comprehensive income, net of tax: | ||||||||||
- Fair value reserve (debt instruments) | – | – | – | – | – | – | – | – | ||
- Cash flow hedges | – | – | – | – | – | – | – | – | ||
- Pension remeasurement | – | – | – | – | – | – | – | – | ||
- Own credit adjustment | – | – | – | – | – | – | – | – | ||
Total other comprehensive income | – | – | – | – | – | – | ||||
Total comprehensive income | – | – | – | – | – | – | ||||
Issue of other equity instruments | – | – | – | – | – | – | – | – | ||
Repurchase of other equity instruments | – | – | ( | – | – | – | – | – | – | ( |
Dividends on preference shares and other equity instruments | – | – | – | – | – | – | – | – | ( | ( |
At 30 June 2025 | ( | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Condensed Consolidated Income Statement | As originally published | Change | Reclassified | |
£m | £m | £m | ||
Interest and similar income | ||||
Interest expense and similar charges | ( | ( | ||
Net interest income | ||||
Fee and commission income | ||||
Fee and commission expense | ( | ( | ||
Net fee and commission income | ||||
Other operating income | ||||
Regulatory fees and levies | ( | ( | ||
Net operating income | ( | |||
Operating expenses before credit impairment charges, restructuring and specific provisions | ( | ( | ( | |
Credit impairment charges | ( | ( | ||
Restructuring and specific provisions | ( | ( | ||
Total credit impairment charges, restructuring and specific provisions | ( | ( | ||
Profit before tax | ||||
Tax on profit | ( | ( | ||
Profit after tax |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Key judgements | –Establishing the criteria for a significant increase in credit risk (SICR) and, for corporate borrowers, internal credit risk rating |
–Determining the need for any judgemental adjustments | |
Key estimates | –Forward-looking multiple economic scenario assumptions |
–Probability weights assigned to multiple economic scenarios | |
–Expected future cash flows for individually assessed Stage 3 corporate exposures | |
–Collateral valuations of individually assessed Stage 3 corporate exposures |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Key judgements | –Determining whether a present obligation exists |
–Determining the likely outcome of future legal decisions | |
Key estimates | –Probability, timing, nature and amount of any outflows that may arise from past events |
Key judgements | –Setting the criteria for constructing the corporate bond yield curve used to determine the discount rate |
–Determining the methodology for setting the inflation assumption | |
Key estimates | –Discount rate applied to future cash flows |
–Rate of price inflation | |
–Expected lifetime of the schemes' members | |
–Valuation of pension fund assets whose values are not based on market observable data |
Key judgement: | –Determining the basis of goodwill impairment testing methodology, including the need for planning assumptions and internal capital allocations |
Key estimates: | –Forecast cash flows for cash generating units |
–Discount rates which factor in risk-free rates and applicable risk premiums | |
All of these variables are subject to fluctuations in external market rates and economic conditions beyond management’s control |
Key judgement: | –Determining the valuation methodologies for assets and liabilities acquired |
Key estimates: | –Funding mix |
–Funding spread |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Retail & Business Banking | Consumer Finance | Corporate & Commercial Banking | Corporate Centre | Total | |
30 June 2026 | £m | £m | £m | £m | £m |
Net interest income | |||||
Non-interest income/(expense) | ( | ||||
Net operating income | |||||
Operating expenses before credit impairment charges, restructuring and specific provisions | ( | ( | ( | ( | ( |
Credit impairment (charges) | ( | ( | ( | ( | |
Restructuring and specific provisions | ( | ( | ( | ( | ( |
Total credit impairment charges, restructuring and specific provisions | ( | ( | ( | ( | ( |
Profit/(loss) before tax | ( | ( | |||
Revenue/(expense) from external customers | ( | ||||
Inter-segment (expense)/revenue | ( | ( | |||
Net operating income | |||||
Customer loans | |||||
Customer deposits |
30 June 2025 | £m | £m | £m | £m | £m |
Net interest income | |||||
Non-interest income/(expense) | ( | ||||
Net operating income/(expense) | ( | ||||
Operating expenses before credit impairment charges, restructuring and specific provisions | ( | ( | ( | ( | |
Credit impairment (charges) | ( | ( | ( | ( | |
Restructuring and specific provisions | ( | ( | ( | ( | |
Total credit impairment charges, restructuring and specific provisions | ( | ( | ( | ( | |
Profit/(loss) before tax | ( | ||||
Revenue/(expense) from external customers | ( | ||||
Inter-segment (expense)/revenue | ( | ( | |||
Net operating income/(expense) | ( | ||||
At 31 December 2025 | |||||
Customer loans | ( | ||||
Customer deposits |
Net carrying amount | ||||
Assets | Liabilities | |||
30 June 2026 | 31 December 2025 | 30 June 2026 | 31 December 2025 | |
£m | £m | £m | £m | |
Customer balances (gross) | ||||
Loan loss allowance | ( | ( | – | – |
Customer balances (net) | ||||
Intercompany balances (including joint ventures) | ||||
Accrued interest | ||||
Other items | ( | ( | ||
Loans and advances to customers / Deposits by customers | ||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 30 June 2025 | |
£m | £m | |
Staff costs | ||
Operational losses (See Note 21) | ||
Other administration expenses | ||
Depreciation, amortisation and impairment | ||
30 June 2026 | 30 June 2025 | |
£m | £m | |
Loans and advances to customers | ||
Recoveries of loans and advances, net of collection costs | ||
Off-balance sheet credit exposures (See Note 21) | ( | |
0 |
30 June 2026 | 30 June 2025 | |
£m | £m | |
Profit before tax | ||
Tax calculated at the statutory rate of | ||
Bank surcharge on profits | ||
Non-deductible preference dividends paid | ||
Non-deductible UK Bank Levy | ||
Other non-deductible costs and non-taxable income | ||
Tax relief on dividends in respect of other equity instruments | ( | ( |
Adjustment to prior year provisions | ( | |
Tax on profit |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | ||||||
Fair value | Fair value | ||||||
Notional amount | Assets | Liabilities | Notional amount | Assets | Liabilities | ||
£m | £m | £m | £m | £m | £m | ||
Derivatives held for trading: | |||||||
Exchange rate contracts | |||||||
Interest rate contracts | |||||||
Inflation rate contracts | |||||||
Equity and credit contracts | |||||||
Total derivatives held for trading | |||||||
Derivatives held for hedging | |||||||
Designated as fair value hedges: | |||||||
Exchange rate contracts | |||||||
Interest rate contracts | |||||||
Inflation rate contracts | |||||||
0 | |||||||
Designated as cash flow hedges: | |||||||
Exchange rate contracts | |||||||
Interest rate contracts | |||||||
1 | |||||||
Total derivatives held for hedging | |||||||
Derivative netting1 | – | ( | ( | – | ( | ( | |
Total derivatives | |||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Loans and advances to customers: | ||
Other debt instruments | ||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Loans and advances to customers | ||
Credit impairment loss allowances on loans and advances to customers | ( | ( |
Residual value and voluntary termination provisions on finance leases | ( | ( |
Net loans and advances to customers |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Mortgage-backed master trust structures: | ||
– Holmes | ||
– Fosse | ||
Other mortgage-backed securitisation structures: | ||
– Duncan | ||
Other asset-backed securitisation structures: | ||
– Repton | ||
Total securitisation programmes | ||
Covered bond programme: | ||
–€ | ||
–£ | ||
Total securitisation and covered bond programmes |
Internal issuances | External issuances | Internal redemptions | External redemptions | ||||||||
H1-26 | H1-25 | H1-26 | H1-25 | H1-26 | H1-25 | H1-26 | H1-25 | ||||
£m | £m | £m | £m | £m | £m | £m | £m | ||||
Mortgage-backed master trust structures: | |||||||||||
–Holmes | |||||||||||
Covered bond programme: | |||||||||||
–€ | |||||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Agreements with banks | ||
Agreements with customers | ||
0 |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Debt securities | ||
Property | Office fixtures and equipment | Computer software | Operating lease assets | Right-of-use assets | Total1 | |
£m | £m | £m | £m | £m | £m | |
Cost: | ||||||
At 1 January 2026 | ||||||
Acquisition of business | ||||||
Additions | ||||||
Disposals | ( | ( | ( | ( | ( | |
At 30 June 2026 | ||||||
Accumulated depreciation and impairment: | ||||||
At 1 January 2026 | ||||||
Charge for the period | ||||||
Impairment during the period | ||||||
Disposals | ( | ( | ( | ( | ( | |
At 30 June 2026 | ||||||
Carrying amount |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Items in the course of transmission1 | ||
Deposits held as collateral | ||
Other deposits2 | ||
Amounts due to other Santander UK Group Holdings plc subsidiaries | ||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Demand and time deposits1 | ||
Amounts due to other Santander UK Group Holdings plc subsidiaries | ||
Amounts due to Santander UK Group Holdings plc2 | ||
Amounts due to fellow Banco Santander subsidiaries and joint ventures | ||
0 |
30 June 2026 | 31 December 2025 | |
£m | £m | |
Agreements with banks | ||
Agreements with customers | ||
0 |
30 June 2026 | 31 December 2025 | |
£m | £m | |
Structured Notes Programmes | ||
Structured deposits | ||
Zero Amortising Guaranteed Notes | ||
0 |
30 June 2026 | 31 December 2025 | |
£m | £m | |
Medium-term notes | ||
Downstreamed from Santander UK Group Holdings plc to Santander UK plc | ||
Euro € | ||
£ | ||
US $ | ||
Certificates of deposit | ||
Credit linked notes | ||
Securitisation programmes | ||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Customer remediation - Motor | Restructuring | Property | Other - restructuri ng and specific provisions | ECL on undrawn facilities and guarantees | Regulatory levies and fees | Bank Levy | Litigation and other regulatory | Customer remediation - other | Other - fraud and operational losses | Total | |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 January 2026 | |||||||||||
Additional provisions | |||||||||||
Provisions released | ( | ( | ( | ||||||||
Utilisation and other | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |
Reclassification from provisions to other assets | |||||||||||
At 30 June 2026 | |||||||||||
Income statement line | Restructuring and specific provisions | Credit impairment charges | Regulatory fees and levies | Operating expenses | |||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Assets/(liabilities) | ||
Funded defined benefit pension scheme - surplus | ||
Unfunded pension and post-retirement medical benefits | ( | ( |
Total net assets |
30 June 2026 | 30 June 2025 | |
£m | £m | |
(Loss) on plan assets (excluding amounts included in net interest expense) | ( | ( |
Actuarial gains arising from changes in demographic assumptions | ||
Actuarial (losses) arising from experience adjustments | ( | ( |
Actuarial gains arising from changes in financial assumptions | ||
Pension remeasurement | ( |
30 June 2026 | 31 December 2025 | |
£m | £m | |
Present value of defined benefit obligations | ( | ( |
Fair value of scheme assets | ||
Net defined benefit assets |
30 June 2026 | 31 December 2025 | |
% | % | |
To determine benefit obligations1: | ||
- Discount rate for scheme liabilities | ||
- General price inflation | ||
- General salary increase | ||
- Expected rate of pension increase |
Years | Years | |
Longevity at 60 for current pensioners, on the valuation date: | ||
- Males | ||
- Females | ||
Longevity at 60 for future pensioners currently aged 40, on the valuation date: | ||
- Males | ||
- Females |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
(Decrease)/increase | |||
30 June 2026 | 31 December 2025 | ||
Assumption | Change in pension obligation at period end from | £m | £m |
Discount rate | ( | ( | |
General price inflation | |||
Mortality | |||
30 June 2026 | 31 December 2025 | |
£m | £m | |
£ | ||
Undated subordinated liabilities | ||
Dated subordinated liabilities | ||
0 |
30 June 2026 | 31 December 2025 | |
£m | £m | |
Guarantees given to third parties | ||
Formal standby facilities, credit lines and other commitments | ||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Interest rate | Next call date | 30 June 2026 | 31 December 2025 | |
% | £m | £m | ||
AT1 securities: | ||||
- £ | March 2026 | |||
- £ | June 2027 | |||
- £ | Sept 2029 | |||
- £ | Sept 2030 | |||
- £ | Sept 2031 | |||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | ||||
Fair | Carrying | Fair | Carrying | ||
value | value | value | value | ||
£m | £m | £m | £m | ||
Assets | |||||
Loans and advances to customers | |||||
Loans and advances to banks | |||||
Reverse repurchase agreements - non-trading | |||||
Other financial assets at amortised cost | |||||
Liabilities | |||||
Deposits by customers | |||||
Deposits by banks | |||||
Repurchase agreements - non-trading | |||||
Debt securities in issue | |||||
Subordinated liabilities | |||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
30 June 2026 | 31 December 2025 | ||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | Valuation | |||
£m | £m | £m | £m | £m | £m | £m | £m | technique | |||
Assets | |||||||||||
Derivative financial instruments | Exchange rate contracts | ||||||||||
Interest rate contracts | |||||||||||
Inflation rate contracts | |||||||||||
Equity and credit contracts | |||||||||||
Netting | ( | ( | ( | ( | |||||||
Other financial assets at FVTPL | Loans and advances to customers | ||||||||||
Debt securities and other debt instruments | |||||||||||
Financial assets at FVOCI | Debt securities | ||||||||||
Total assets at fair value | |||||||||||
Liabilities | |||||||||||
Derivative financial instruments | Exchange rate contracts | ||||||||||
Interest rate contracts | |||||||||||
Inflation rate contracts | |||||||||||
Equity and credit contracts | |||||||||||
Netting | ( | ( | ( | ( | |||||||
Other financial liabilities at FVTPL | Debt securities in issue | ||||||||||
Structured deposits | |||||||||||
Zero Amortising Guaranteed Notes | |||||||||||
Total liabilities at fair value | |||||||||||
30 June 2026 | 31 December 2025 | |
£m | £m | |
Risk-related: | ||
- Bid-offer and trade specific adjustments | ||
- Uncertainty | ||
- Credit risk adjustment | ||
- Funding fair value adjustment | ||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Assets | Liabilities | |||||
Derivatives | Other financial assets at FVTPL | Total | Derivatives | Total | ||
£m | £m | £m | £m | £m | ||
At 1 January 2026 | ( | ( | ||||
Total gains/(losses) recognised: | ||||||
Fair value movements1 | ||||||
Settlements | ( | ( | ( | |||
At 30 June 2026 | ( | ( | ||||
Gains/(losses) recognised in profit or loss/other comprehensive income relating to assets and liabilities held at the end of the period1 | ||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Book value at 30 April 2026 | FV Adjustments | Fair Value at 30 April 2026 | |
£m | £m | £m | |
Assets | |||
Cash and balances at central banks | |||
Derivative financial instruments | |||
Loans and advances to banks | |||
Loans and advances to customers | ( | ||
Other financial assets at amortised cost | ( | ||
Macro hedge of interest rate risk | ( | ||
Financial assets at fair value through other comprehensive income | |||
Intangible assets | |||
Property, plant and equipment | ( | ||
Deferred tax assets | ( | ||
Other assets | |||
Total assets | |||
Liabilities | |||
Deposits by banks | |||
Deposits by customers | ( | ||
Derivative financial instruments | |||
Debt securities in issue | |||
Macro hedge of interest rate risk | ( | ||
Other liabilities | ( | ||
Provisions | ( | ||
Deferred tax liabilities | |||
Subordinated liabilities | |||
Total liabilities | ( | ||
Fair value of net assets acquired | |||
Goodwill arising on acquisition | |||
Non-equity securities purchased | |||
Total consideration Paid/Transferred |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Funding spread assumption | Impact on mortgage fair value | Impact on CDI | Net impact on purchase price allocation |
£m | £m | £m | |
+/- | ( | ||
Discount Rate assumption | Impact on mortgage fair value | Impact on CDI | Net impact on purchase price allocation |
+/- | ( | ( | ( |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
At 30 April 2026 | |
£m | |
Cash, cash balances at central banks and other demand deposits on acquisition | |
Adjustments for items not classified as cash and cash equivalents 1 | ( |
Cash and cash equivalents acquired | |
Cash paid for ordinary shares | ( |
Cash paid for AT1 securities | ( |
Cash paid for debt securities | ( |
Net cash flow from acquisition of TSB | ( |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Shareholder information | ||||
Contents | ||||
Forward-looking statements | 71 | |||
Calculations | 71 | |||
Glossary | 71 | |||
Board changes | 71 | |||
Risk factors | 72 | |||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
Measure | Description and calculation |
Non-interest income | Net fee and commission income plus other operating income. |
POCI ratio | Sum of POCI drawn assets divided by the sum of total drawn assets. |
Stage 1 ratio | The sum of Stage 1 drawn assets divided by the sum of total drawn assets. |
Stage 2 ratio | The sum of Stage 2 drawn assets divided by the sum of total drawn assets. |
Stage 3 ratio | The sum of Stage 3 drawn and Stage 3 undrawn assets divided by the sum of total drawn assets and stage 3 undrawn assets. |
Wholesale funding | Deposits by customers reported in Corporate Centre, debt securities in issue, subordinated liabilities, AT1 issuance and Central Bank facilities, including TFSME and indexed Long-Term Repos used for funding. |
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
CEO review | Financial overview | Risk review | Financial statements | Shareholder information | |||||||||
By: | /s/ Angel Santodomingo | |
Angel Santodomingo | ||
Chief Financial Officer |
Filing Exhibits & Attachments
5 documentsOther Documents
- EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 150.2 KB
- EX-101 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT 125.8 KB
- EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT 494.4 KB
- EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 1021.5 KB
- EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 726.9 KB